Clin Pharmacol Ther. 2010 May;87(5):536-9. doi: 10.1038/clpt.2010.40.

The need for precompetitive integrative bionetwork disease model building.

Source

Sage Bionetworks, Seattle, Washington, USA. friend@sagebase.org

Abstract

If you doubt that there are enormous gaps in the current drug discovery process, you should probably skip to the next article. Yet even while critiques rightly highlight inefficiencies or operational issues, they often miss a fundamental reality: until we better understand diseases as altered bionetworks and view diseases at an individual patient level, efforts to develop effective biomarkers and therapies will be inefficient at best.

PMID:: 20407459; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Save items

Related citations in PubMed

A network view of disease and compound screening. [Nat Rev Drug Discov. 2009]
A network view of disease and compound screening.
Schadt EE, Friend SH, Shaywitz DA. Nat Rev Drug Discov. 2009 Apr; 8(4):286-95.
Review Network systems biology for drug discovery. [Clin Pharmacol Ther. 2010]
Review Network systems biology for drug discovery.
Arrell DK, Terzic A. Clin Pharmacol Ther. 2010 Jul; 88(1):120-5. Epub 2010 Jun 2.
Review Can open-source drug R&D repower pharmaceutical innovation? [Clin Pharmacol Ther. 2010]
Review Can open-source drug R&D repower pharmaceutical innovation?
Munos B. Clin Pharmacol Ther. 2010 May; 87(5):534-6.
Review Can cell systems biology rescue drug discovery? [Nat Rev Drug Discov. 2005]
Review Can cell systems biology rescue drug discovery?
Butcher EC. Nat Rev Drug Discov. 2005 Jun; 4(6):461-7.
Review Taking a systems approach to the identification of novel therapeutic targets and biomarkers. [Curr Pharm Biotechnol. 2010]
Review Taking a systems approach to the identification of novel therapeutic targets and biomarkers.
Dunn DA, Apanovitch D, Follettie M, He T, Ryan T. Curr Pharm Biotechnol. 2010 Nov; 11(7):721-34.

See reviews... See all...

Cited by 3 PubMed Central articles

Developing predictive molecular maps of human disease through community-based modeling. [Nat Genet. 2012]
Developing predictive molecular maps of human disease through community-based modeling.
Derry JM, Mangravite LM, Suver C, Furia MD, Henderson D, Schildwachter X, Bot B, Izant J, Sieberts SK, Kellen MR, et al. Nat Genet. 2012 Jan 27; 44(2):127-30. Epub 2012 Jan 27.
First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium. [Am J Trop Med Hyg. 2012]
First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium.
Musselwhite LW, Maciag K, Lankowski A, Gretes MC, Wellems TE, Tavera G, Goulding RE, Guillen E. Am J Trop Med Hyg. 2012 Jan; 86(1):65-74.
Drug Discovery in Academia- the third way? [Expert Opin Drug Discov. 2010]
Drug Discovery in Academia- the third way?
Frearson J, Wyatt P. Expert Opin Drug Discov. 2010 Oct 1; 5(10):909-19.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The need for precompetitive integrative bionetwork disease model building.
The need for precompetitive integrative bionetwork disease model building.
Clin Pharmacol Ther. 2010 May ;87(5):536-9. doi: 10.1038/clpt.2010.40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: